Court Affirms Dismissal of Lipitor Complaints Based on Immunity Statute
December 10, 2008
DOCUMENTS
- Opinion
NEW YORK - A group of Lipitor plaintiffs who claimed they developed neurological and psychological injuries after taking the drug failed to plead any allegations that would preclude their claims from dismissal based on Michigan's drug manufacture immunity statute, a state appeals court has held. Devore v. Pfizer Inc., No. 09194 (N.Y. Sup. Ct., App. Div. First Dept.).
The New York Supreme Court First Department Appellate division ruled Nov. 20 that a trial court correctly dismissed the three cases based on the plaintiffs' failure to allege that Lipitor manufacturer Pfizer Inc. fraudulently obtained FDA approval for the drug.
Evidence …
UPCOMING CONFERENCES
HarrisMartin's MDL Conference: Depo-Provera and Current MDL Cases
January 29, 2025 - Miami Beach, FL
The Coral Ballroom at the Fontainebleau Miami Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick